Inhibitory effect of metyrapone on glucose utilization by brain and muscle and on insulin release by the pancreas.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003864:Depression, Chemical; D005260:Female; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008797:Metyrapone / Q000494:pharmacology*; D009132:Muscles / Q000378:metabolism*; D010084:Oxidation-Reduction; D010179:Pancreas / Q000378:metabolism*; D051381:Rats
D007328:Insulin; D005947:Glucose; D008797:Metyrapone